Related Experiment Video
Updated: Aug 27, 2025
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.3K
What's in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment
Marina Gaeta Gazzola1,2, Emma Maclean2,3, Mark Beitel1,2,4
1Yale School of Medicine, New Haven, CT, USA.
Journal of General Internal Medicine
|September 27, 2022
Summary
Patients with opioid use disorder (OUD) prefer destigmatizing terms like "addiction" and "person with an addiction." Terminology preferences varied by race and age, highlighting the need for sensitive language in addiction treatment.
Area of Science:
- Addiction Medicine
- Psychiatry
- Public Health
Background:
- Substance use disorder (SUD) terminology is crucial, yet patient preferences are understudied.
- Opioid use disorder (OUD) patients' views on counselor terminology require examination.
Purpose of the Study:
- To investigate terminology preferences of patients with opioid use disorder (OUD) regarding terms used by addiction counselors.
- To identify preferred terms for presenting problems, collective nouns, and personal descriptors.
Main Methods:
- Cross-sectional survey of 450 adult patients with OUD in methadone treatment.
- Used Likert scales to assess preferences for various terms.
- Analyzed demographic associations and 12-step program influence on term preference.
Main Results:
- Patients favored terms like "addiction," "substance use," and "person with an addiction."
- "Client," "patient," and "guest" were preferred collective nouns.
- Significant differences in preferences were noted based on race and age; 12-step involvement correlated with preferring "addict."
Conclusions:
- Patient preferences align with guidelines for medically accurate and destigmatizing language in addiction treatment.
- Observed demographic variations in terminology preferences warrant further investigation.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.8K
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.3K
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
394
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
394
01:25Analgesia and Pain Management
763
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
763
01:17Phase II Reactions: Methylation Reactions
294
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
294
01:15Drug Abuse and Addiction: Pharmacological Phenomena
628
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
628
01:17Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
01:15Drug Dosage Regimen: Overview
3.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.7K